AEROPATH

"The identification, characterisation and exploitation of novel Gram-negative drug targets."

 Coordinatore UNIVERSITY OF DUNDEE 

 Organization address address: Nethergate
city: DUNDEE
postcode: DD1 4HN

contact info
Titolo: Ms.
Nome: Zoe
Cognome: Kidd
Email: send email
Telefono: +44(0)1382 384047
Fax: +44(0)1382 385438

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 6˙049˙979 €
 EC contributo 4˙591˙463 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-B
 Funding Scheme CP-FP
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-11-01   -   2012-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF DUNDEE

 Organization address address: Nethergate
city: DUNDEE
postcode: DD1 4HN

contact info
Titolo: Ms.
Nome: Zoe
Cognome: Kidd
Email: send email
Telefono: +44(0)1382 384047
Fax: +44(0)1382 385438

UK (DUNDEE) coordinator 0.00
2    KAROLINSKA INSTITUTET

 Organization address address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177

contact info
Titolo: Ms.
Nome: Jill
Cognome: Blomstrand
Email: send email
Telefono: +46 (0)8 52487687
Fax: +46 (0)8 304452

SE (STOCKHOLM) participant 0.00
3    LIONEX GMBH

 Organization address address: Salzdahlumer Strasse 196
city: BRAUNSCHWEIG
postcode: 38126

contact info
Titolo: Prof.
Nome: Mahavir
Cognome: Singh
Email: send email
Telefono: 495313000000
Fax: 495313000000

DE (BRAUNSCHWEIG) participant 0.00
4    Mfd-diagnostics GmbH

 Organization address address: Mikroforum Ring 2
city: Wendelsheim
postcode: 55234

contact info
Titolo: Dr.
Nome: Bernd
Cognome: Lecher
Email: send email
Telefono: 0049-6734-911200
Fax: 0049-6734-911222

DE (Wendelsheim) participant 0.00
5    THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS

 Organization address address: NORTH STREET 66 COLLEGE GATE
city: ST ANDREWS FIFE
postcode: KY16 9AJ

contact info
Titolo: Ms.
Nome: Fiona
Cognome: Thomson
Email: send email
Telefono: +44(0)1334 462215
Fax: +44(0)1334 462217

UK (ST ANDREWS FIFE) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

inhibitors    antimicrobial    biology    negative    wpii    aeruginosa    bacteria    biochemical    gram    drug    screening    characterisation    ligands    wpi   

 Obiettivo del progetto (Objective)

'An ambitious long-term programme of multidisciplinary research with two closely linked objectives is proposed to support antimicrobial drug development. Firstly, to advance understanding, at the molecular level, of fundamental and important aspects of the biology of Gram-negative bacteria using the important pathogen model Pseudomonas aeruginosa. Secondly, and most important, to exploit our discoveries and develop ligands and inhibitors (hit and lead compounds) with the potential to underpin the discovery of improved therapies for Gram-negative infections. The research covers five distinct areas, or work packages. (WPI) The experimental validation and therefore identification of novel targets by gene knockout in P. aeruginosa. (WPII) Cloning, characterisation, biochemical and structural biology, of the novel targets. (WPIII) A directed, search for ligands/inhibitors, exploiting data from WPI and WPII, for these validated antimicrobial drug targets by virtual screening (VS) and assessment of druggabilty, high-throughput screening (HTS) of a carefully prioritised subset of targets. (WPIV) The characterisation of the interactions formed between the drug target and the ligand/inhibitor by biochemical and crystallographic study, computational modelling and then design and modelling to enhance binding properties. (WPV) The initial biological testing for efficacy against Gram-negative bacteria.'

Altri progetti dello stesso programma (FP7-HEALTH)

QUASER (2010)

Quality and safety in European Union hospitals: A research-based guide for implmeenting best practice and a framework for assessing performance

Read More  

LACTOBODY (2008)

Production and delivery of antibody fragments against gastrointestinal pathogens by lactobacilli

Read More  

LEUKOTREAT (2010)

Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials

Read More